This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Celgene Corporation. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Hsiling Chiu: Innovator in Cancer Treatment
Introduction
Hsiling Chiu is a notable inventor based in Livingston, NJ (US). He has made significant contributions to the field of oncology through his innovative research and development of treatment methods for hematological cancers and solid tumors. His work is particularly focused on combination therapies that enhance treatment efficacy.
Latest Patents
Hsiling Chiu holds a patent for a method titled "Combination therapy for treatment of hematological cancers and solid tumors." This patent outlines methods for treating, preventing, and managing these types of cancers using a combination therapy that includes 3-(5-amino-2-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione and checkpoint inhibitors. This innovative approach aims to improve patient outcomes in cancer treatment.
Career Highlights
Chiu is currently employed at Celgene Corporation, a leading biopharmaceutical company known for its focus on innovative therapies for cancer and other serious diseases. His work at Celgene has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of Hsiling Chiu's coworkers include Anita Gandhi and Michael Pourdehnad. Their collaborative efforts in research and development have further advanced the understanding and treatment of cancer.
Conclusion
Hsiling Chiu's contributions to cancer treatment through his innovative patent and work at Celgene Corporation highlight his role as a significant figure in the field of oncology. His dedication to improving patient care through combination therapies is commendable and reflects the ongoing advancements in medical research.